How many Cardiologists will be voting on this committee?
DD:A lot of cardiologists no longer believe that surrogate endpoints (such as triglycerides, HDL, etc.) predict risk of CV events. Waiting for results of REDUCE-IT seems like a kneejerk kind of response to the question. All told, I expect the panel to be positive, but not unanimous.
Market Data 
Markets 
AI
